Fast, safe, and cost-effective, with the highest positive predictive value among comparable non-invasive tests.
Screening test for preeclampsia in asymptomatic pregnant women.
Whole exome sequencing (WES)- all exons of the human genome, Molecular Karyotype (CMA), Conventional Karyotype
Molecular testing based on customized gene combinations for the detection of hereditary risk for: Breast and gynecological cancers, colorectal, lung, and gastrointestinal cancers, prostate, pancreatic, kidney, skin, and thyroid cancers, among others
Genetic analysis for blood-related cancers, including: Leukemias, Lymphomas, Myelodysplastic syndromes (MDS) and other hematologic malignancies